SARS News and Research

RSS

mRNA COVID boosters are effective against severe Omicron for at least six months

A new study published in the journal JAMA Network Open aimed to analyze the association of the types of vaccine and their combination with the waning of protection against Omicron in residents of Singapore who were aged 30 years and above and had received at least two doses of a COVID vaccine.

30 Aug 2022

Study reveals a 'stealing' mechanism that contributes to antibody diversity

A few years ago, Professor Kathrin de la Rosa and her colleagues in the lab of the Swiss immunologist Antonio Lanzavecchia made an unusual discovery.

29 Aug 2022

Post-acute sequelae of SARS-CoV-2 infection in children appears to be lower than in adults

A new study conducted by the National Institutes of Health (NIH) RECOVER Pediatric Electronic Health Records (EHR) Cohort and authored by Suchitra Rao, MD, infectious disease specialist at Children's Hospital Colorado, found that the risk of post-acute sequelae of SARS-CoV-2 infection (PASC), or long COVID, in children appears to be lower than what has been reported in adults.

29 Aug 2022

SARS-CoV-2 antigen levels associated with COVID-19 severity and other clinical outcomes

The amount of SARS-CoV-2 antigen measured in the blood of patients hospitalized with COVID-19 is associated with illness severity and other clinical outcomes, according to a new study published in the Annals of Internal Medicine.

29 Aug 2022

Viruses modify host cellular machinery to produce high amounts of viral progeny

The study, published in Nature Communications, shows a new mechanism whereby viruses modify cellular machinery so that it can better read the instructions in the genome of the invading virus.

29 Aug 2022

Oncolytic viruses boost the immune capacity to effectively target and destroy cancer cells

The immune system has evolved to safeguard the body from a wildly diverse range of potential threats. Among these are bacterial diseases, including plague, cholera, diphtheria and Lyme disease, and viral contagions such as influenza, Ebola virus and SARS CoV-2.

29 Aug 2022

Herpesvirus-6 and Epstein–Barr virus reactivation across acute SARS-CoV-2 patients

In a new story, scientists explored human herpesvirus-6 (HHV-6) and Epstein–Barr virus (EBV) reactivation among acute coronavirus disease 2019 (COVID-19) patients.

29 Aug 2022

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

Researchers investigated whether early treatment with oral antivirals prevented all-cause mortality in hospitalized patients infected with SARS-CoV-2 new variant of concern Omicron BA.2 subvariant.

29 Aug 2022

Protection against SARS-CoV-2 reinfections in the Qatari population

Researchers evaluated protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection.

29 Aug 2022

The effectiveness of nirmatrelvir in preventing severe COVID-19 outcomes during the Omicron surge

Researchers assessed the clinical efficacy of nirmatrelvir in preventing severe COVID-19 in Israel during the Omicron wave.

29 Aug 2022

Is there an association between the gut microbiome of people within different countries and the severity of COVID-19?

Researchers explored the complex relationship between the gut microbiome of people in different countries and the observed COVID-19 severity, measured as the hospitalization rate of the corresponding country.

29 Aug 2022

High-throughput proteomics reveals pregnancy-specific responses to COVID-19

Researchers evaluated pregnancy-specific responses to SARS-CoV-2 infection.

29 Aug 2022

What are the effects of e-cigarettes and their constituents on SARS-CoV-2 infection?

In a new study, researchers evaluated whether e-cigarette (EC) aerosols promoted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

29 Aug 2022

The incidence rate, distribution, characteristics, and outcomes of neonatal COVID-19

Researchers assessed the epidemiology of neonatal COVID-19 infections.

29 Aug 2022

Contact risks for COVID-19 transmission to healthcare personnel

Researchers analyzed the contact risks for SARS-CoV-2 spread to medical professionals in an infection outbreak in a hospital ward.

29 Aug 2022

Researchers propose a novel, non-discriminatory classification of the monkeypox virus

Researchers proposed a novel, non-discriminatory classification of the monkeypox virus.

29 Aug 2022

How does the maternal immune response balance SARS-CoV-2 antiviral responses with transplacental transfer of protection to the fetus?

Researchers found that in SARS-CoV-2 maternal infection, the balance between antiviral response and transplacental transfer of humoral and cellular protection relies on maternal IL-6 and IL10.

29 Aug 2022

SARS News and Research

mRNA COVID boosters are effective against severe Omicron for at least six months

Study reveals a 'stealing' mechanism that contributes to antibody diversity

Post-acute sequelae of SARS-CoV-2 infection in children appears to be lower than in adults

SARS-CoV-2 antigen levels associated with COVID-19 severity and other clinical outcomes

Viruses modify host cellular machinery to produce high amounts of viral progeny

Oncolytic viruses boost the immune capacity to effectively target and destroy cancer cells

Herpesvirus-6 and Epstein–Barr virus reactivation across acute SARS-CoV-2 patients

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

Protection against SARS-CoV-2 reinfections in the Qatari population

The effectiveness of nirmatrelvir in preventing severe COVID-19 outcomes during the Omicron surge

Is there an association between the gut microbiome of people within different countries and the severity of COVID-19?

High-throughput proteomics reveals pregnancy-specific responses to COVID-19

What are the effects of e-cigarettes and their constituents on SARS-CoV-2 infection?

The incidence rate, distribution, characteristics, and outcomes of neonatal COVID-19

Contact risks for COVID-19 transmission to healthcare personnel

Researchers propose a novel, non-discriminatory classification of the monkeypox virus

How does the maternal immune response balance SARS-CoV-2 antiviral responses with transplacental transfer of protection to the fetus?

Study shows SARS-CoV-2 infection provides strong protection from reinfection

Research characterizes clinical and epidemiologic features of SARS-CoV-2 in pets

What is the impact of the SARS-CoV-2 omicron wave in South Africa?

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News